Endocare Eyes Niche Market In Prostate Cancer Salvage Therapy
This article was originally published in The Gray Sheet
Executive Summary
Endocare's request for Medicare coverage of cryosurgery to treat prostate cancer radiation-therapy "salvage" patients likely will not be referred to the Medicare Coverage Advisory Committee, according to the Health Care Financing Administration.
You may also be interested in...
HCFA Expands Cryosurgery Policy, Turning Down AUA's Covering Fire
The Health Care Financing Administration has extended Medicare coverage of prostate cryosurgery to radiation therapy salvage patients although the American Urological Association did not fully endorse the procedure.
HCFA Expands Cryosurgery Policy, Turning Down AUA's Covering Fire
The Health Care Financing Administration has extended Medicare coverage of prostate cryosurgery to radiation therapy salvage patients although the American Urological Association did not fully endorse the procedure.
Endocare And Galil Relations Cold As Prostate Cryosurgery Market Heats Up
The number of cryoablation procedures to treat prostate cancer is expected to grow more than 100% over the next year, fueled by favorable outcomes from a five-year study evaluating Endocare's Cryocare system, the company predicts.